Discounted Cash Flow
Scienjoy Holding Corp. Foreign
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $914.6m | $22.3m | $-174.1k | 2.4% | $7.73 |
| 2020 | $187.3m (-79.5%) | $4.0m (-82.0%) | $3.5m (2117.0%) | 2.1% (-12.1%) | $1.16 (-85.0%) |
| 2021 | $262.0m (39.9%) | $4.0m (-1.1%) | $2.7m (-23.8%) | 1.5% (-29.3%) | $0.87 (-25.0%) |
| 2022 | $283.2m (8.1%) | $4.2m (5.1%) | $1.2m (-55.5%) | 1.5% (-2.8%) | $0.71 (-18.4%) |
| 2023 | $1.5b (417.3%) | $-643.8k (-115.5%) | $2.1m (79.2%) | -0.0% (-103.0%) | $-0.11 (-115.5%) |
| 2024 | $1.4b (-6.9%) | $807.4k (225.4%) | $1.4m (-35.5%) | 0.1% (234.8%) | $0.13 (218.2%) |
| 2025 | $1.2b (-8.9%) | $-12.5m (-1643.8%) | $1.5m (7.4%) | -1.0% (-1795.2%) | $-2.01 (-1646.2%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
SEC filings report in CNY. Values above are converted to USD for comparison with the US-listed share price.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.